School of Medicine
Showing 181-190 of 1,295 Results
-
Kathryne Sanserino MD, FACOG, MSCP
Clinical Assistant Professor, Obstetrics & Gynecology - General
BioDr. Sanserino is a gynecologist whose work focuses on providing gynecologic care for cancer survivors, patients living with cancer, and at-risk women. She recognizes that patients who have faced cancer have unique gynecologic needs and she works closely with her colleagues in the Women's Cancer Center to provide sensitive, comprehensive gynecologic care for these women.
Some of the specific gynecologic symptoms that cancer survivors often experience include:
- Chemotherapy induced menopause
- Surgery induced menopause
- Management of menopausal symptoms with a history of hormone sensitive cancers
- Treatment of genitourinary symptoms of hormone blocking medications
- Decisions about decisions about oophorectomy (ovary removal) for breast cancer patients and women at high risk for breast cancer
- Discussions about family planning (fertility preservation, contraception, pregnancy) after cancer
- Sexual side effects such as lower libido, decreased arousal, and pain with intercourse
- Complications from Tamoxifen or Aromatase Inhibitor therapy
She is also a physician in the Menopause & Healthy Aging Program and works to help patients manage the symptoms of menopause and perimenopause, diagnose and treat female sexual dysfunction, and utilize lifestyle medicine to treat and decrease the risk of chronic conditions associated with aging. She is a Menopause Society Certified Practitioner (MSCP).
She has been recognized as an outstanding medical educator, winning several awards for resident education. She is currently one of the assistant residency program directors for the OB/GYN residency. In addition to her office clinic work, she performs gynecologic surgeries and works with the OB/GYN residents to provide inpatient gynecologic care and perform emergency surgeries.
She has a background in community health work and quality improvement. She is committed to safe, equitable health care and has a patient-centered, evidence-based practice approach.
Dr. Sanserino speaks fluent Spanish. -
Calvin Santiago, MD, FRCPC, MSc (he/him)
Clinical Assistant Professor, Adult Neurology
BioDr. Santiago is a board-certified neurologist with Stanford Health Care. He is a clinical assistant professor in the Department of Neurology and Neurological Sciences, Division of Comprehensive Neurology at Stanford University School of Medicine.
Dr. Santiago diagnoses and treats a wide range of neurological conditions, including headache, epilepsy, memory disorders, movement disorders, and neuropathy. He has a special focus on improving access to neurological care, including reducing patient wait times and directing patients to the most appropriate care provider by streamlining physician referrals. He also provides LGBTQ+ care.
His research interests include executive functioning and processing speed in older adults with coronary artery disease and using CT angiography in patients with acute ischemic stroke and transient ischemic attack. He has also researched speech-language changes in patients with mild cognitive impairment and Alzheimer’s disease.
Dr. Santiago has published in multiple peer-reviewed journals, including Alzheimer’s Research & Therapy, Alzheimer’s & Dementia, and Cureus: Journal of Medical Science. He has presented to his peers at national and regional meetings, including the Society of Biological Psychiatry Annual Meeting, History of Medicine Days at the University of Calgary, and the Advanced Learning in Palliative Medicine Conference at the University of Toronto.
Dr. Santiago is a member of the American Academy of Neurology, Canadian Neurological Sciences Foundation, and Ontario Medical Association. -
Matteo Santoro Pharm.D., Ph.D.
Postdoctoral Scholar, Pathology
BioDr. Santoro joined Stanford University in March 2021, focusing his research on Parkinson’s disease, neuronal vulnerability, and identification of therapeutic markers in relation to α-synucleinopathies. Currently under the Supervision of Prof. Thomas Montine, he is working on the development of LRRK2 selective inhibitors. Prior to his arrival at Stanford, he held a position as a clinical monitor at Syneos Health, where he gained key knowledge needed to translate lab-based findings into clinical and commercial applications. Previously, Dr. Santoro held a postdoctoral position at the University of Aberdeen (Scotland, UK), working on amyloid-beta extracts from Alzheimer’s disease patients. During his postdoctoral research, Dr. Santoro designed and optimized a cost-effective and rapid assay for the measurement of toxic amyloid-beta species in human biofluids. In 2017, he obtained his Ph.D. (4-year program) at the University of Aberdeen on Parkinson’s disease (PD), immunology, and behavior. The major findings Ph.D. findings were the following: 1) the characterization of a small protein called HMGB1 as an inflammatory mediator in PD; 2) the motor and non-motor behavioral characterization of three neurotoxin based mouse models of PD, 3) the characterization of the innate immune response in PD through the toll-like receptor signaling pathways 4) evaluation of the effects of chronic systemic inflammation on both resident and infiltrating immune cells in the CNS. In 2012, Dr. Santoro attained his Pharm.D. in chemistry and pharmaceutical technology (5-year program) at the University of Calabria (Italy), during which he undertook an internship at King’s College London (SGDP Centre) and worked for over a year on a rat model of stroke.
